We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
As MyoKardia’s head of Digital Health, Charles Wolfus is on a mission to improve patient lives by applying sensors, social media, mobile technology, and artificial intelligence in clinical trials and daily life.
In 2017, Charles led MyoKardia’s multidisciplinary team in the world’s first use of commercial wearables in an interventional drug clinical study. MyoKardia’s phase 2 PIONEER-HCM clinical trial captured PPG data as an exploratory endpoint. Through subsequent machine-learning analysis MyoKardia was able to detect HCM with greater than 95% accuracy.
Charles is a recognized thought leader in the fusion of wearable technology and its use in clinical trials. He passionately believes that these technologies will improve healthcare for all. Charles has been a technology leader in biotech for nearly 20 years and a featured a speaker at international digital heath symposia. He is licensed to practice law in the State of California.
This speaker's sessions: